Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55.6M
-
Number of holders
-
149
-
Total 13F shares, excl. options
-
48.2M
-
Shares change
-
+198K
-
Total reported value, excl. options
-
$7.13B
-
Value change
-
+$38.8M
-
Put/Call ratio
-
0.33
-
Number of buys
-
88
-
Number of sells
-
-60
-
Price
-
$147.90
Significant Holders of Ascendis Pharma A/S - ADR (ASND) as of Q2 2020
181 filings reported holding ASND - Ascendis Pharma A/S - ADR as of Q2 2020.
Ascendis Pharma A/S - ADR (ASND) has 149 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.2M shares
of 55.6M outstanding shares and own 86.82% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (7.06M shares), RA CAPITAL MANAGEMENT, L.P. (4.91M shares), FMR LLC (4.8M shares), Artisan Partners Limited Partnership (4.03M shares), BAKER BROS. ADVISORS LP (3.39M shares), JANUS HENDERSON GROUP PLC (2.42M shares), Vivo Capital, LLC (1.8M shares), WELLINGTON MANAGEMENT GROUP LLP (1.79M shares), Avoro Capital Advisors LLC (1.75M shares), and EVENTIDE ASSET MANAGEMENT, LLC (1.71M shares).
This table shows the top 149 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.